Kneu Health is a British healthtech company revolutionizing neurodegenerative care through AI-powered smartphone technology. Founded in 2019, Kneu uses clinically validated algorithms to monitor motor, speech, and cognitive functions continuously. Its FDA-cleared platform, based on Oxford University research, detects early signs of Parkinson’s and dementia, enabling precision treatment before symptoms worsen. With one of the world’s largest neurological datasets, Kneu transforms routine smartphone interactions into predictive health insights. Partnering with organizations like NHS and Cedars-Sinai, Kneu aims to shift care from reactive to proactive, improving patient outcomes and redefining how clinicians track neurological decline worldwide.